Weiwei Wang

7.9k total citations
283 papers, 5.6k citations indexed

About

Weiwei Wang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Weiwei Wang has authored 283 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Molecular Biology, 47 papers in Surgery and 46 papers in Oncology. Recurrent topics in Weiwei Wang's work include Mesenchymal stem cell research (24 papers), RNA Interference and Gene Delivery (19 papers) and MicroRNA in disease regulation (16 papers). Weiwei Wang is often cited by papers focused on Mesenchymal stem cell research (24 papers), RNA Interference and Gene Delivery (19 papers) and MicroRNA in disease regulation (16 papers). Weiwei Wang collaborates with scholars based in China, Germany and United States. Weiwei Wang's co-authors include Nan Ma, Wenzhong Li, Gustav Steinhoff, Andreas Lendlein, Dario Furlani, Lee‐Lee Ong, Xun Xu, Karen Bieback, Shangli Zhang and Jing Liu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Weiwei Wang

262 papers receiving 5.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Weiwei Wang 2.5k 934 867 697 660 283 5.6k
Chris Jackson 1.4k 0.6× 816 0.9× 893 1.0× 399 0.6× 448 0.7× 170 6.4k
Jing Chen 3.0k 1.2× 444 0.5× 1.3k 1.5× 429 0.6× 576 0.9× 176 6.1k
Noel M. Caplice 2.8k 1.1× 1.8k 1.9× 666 0.8× 960 1.4× 608 0.9× 114 6.0k
Zhongmin Liu 2.9k 1.2× 955 1.0× 935 1.1× 641 0.9× 745 1.1× 235 7.1k
Robert Flaumenhaft 2.7k 1.1× 775 0.8× 732 0.8× 513 0.7× 727 1.1× 161 7.7k
Liang Tang 2.5k 1.0× 836 0.9× 1.3k 1.5× 825 1.2× 887 1.3× 220 6.0k
Jianan Wang 2.2k 0.9× 929 1.0× 928 1.1× 494 0.7× 296 0.4× 291 5.4k
Jingping Liu 2.7k 1.1× 750 0.8× 581 0.7× 384 0.6× 223 0.3× 162 5.6k
Mohammad Nouri 2.4k 1.0× 609 0.7× 813 0.9× 287 0.4× 532 0.8× 272 6.6k
Caroline Bouzin 2.5k 1.0× 810 0.9× 1.2k 1.4× 203 0.3× 636 1.0× 174 5.6k

Countries citing papers authored by Weiwei Wang

Since Specialization
Citations

This map shows the geographic impact of Weiwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Wang more than expected).

Fields of papers citing papers by Weiwei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Wang. The network helps show where Weiwei Wang may publish in the future.

Co-authorship network of co-authors of Weiwei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Wang. A scholar is included among the top collaborators of Weiwei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Wang. Weiwei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Wei, Yonglong Jin, Jie Wang, et al.. (2024). Proton Beam Therapy for a Rare Anaplastic Pleomorphic Xanthoastrocytoma: Case Report and Literature Review. International Journal of Particle Therapy. 15. 100736–100736.
2.
Wang, Weiwei, Yinbin Zhang, Jia Li, et al.. (2024). Establishment of patient‐derived organoids for guiding personalized therapies in breast cancer patients. International Journal of Cancer. 155(2). 324–338. 12 indexed citations
3.
Qu, Jingkun, Chaofan Li, Yusheng Wang, et al.. (2023). Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients. Journal of Clinical Medicine. 12(9). 3097–3097. 8 indexed citations
4.
Sun, Xue, et al.. (2023). Detection of Circulating Tumor DNA in Plasma Using Targeted Sequencing. Methods in molecular biology. 2695. 27–46. 1 indexed citations
5.
Shen, Pingping, et al.. (2023). Interaction of bioactive kaempferol with HMGB1: Investigation by multi-spectroscopic and molecular simulation methods. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 292. 122360–122360. 4 indexed citations
6.
Sun, Wenqi, Weiwei Wang, Peng Yan, et al.. (2023). Lactulose vs Polyethylene Glycol for Bowel Preparation: A Single-Center, Prospective, Randomized Controlled Study Based on BMI. Clinical and Translational Gastroenterology. 15(1). e00652–e00652. 5 indexed citations
7.
Shen, Pingping, Yan Peng, Haixia Ge, et al.. (2022). A comprehensive spectral and in silico analysis on the interactions between quercetin, isoquercitrin, rutin and HMGB1. LWT. 169. 113983–113983. 14 indexed citations
8.
Zhang, Yawen, Mengmeng Wang, Fanyi Meng, et al.. (2022). A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis. Cell Death Discovery. 8(1). 238–238. 17 indexed citations
9.
Shen, Pingping, Jing Zhou, Haixia Ge, et al.. (2022). Microbial-Catalyzed Baeyer–Villiger Oxidation for 3,4-seco-Triterpenoids as Potential HMGB1 Inhibitors. ACS Omega. 7(22). 18745–18751. 8 indexed citations
10.
Wang, Weiwei, Tetsuya Okajima, & Hideyuki Takeuchi. (2022). Significant Roles of Notch O-Glycosylation in Cancer. Molecules. 27(6). 1783–1783. 11 indexed citations
12.
Zhu, Zhongyi, Weiwei Wang, Lin Feng, et al.. (2021). Genome profiles of pathologist-defined cell clusters by multiregional LCM and G&T-seq in one triple-negative breast cancer patient. Cell Reports Medicine. 2(10). 100404–100404. 6 indexed citations
13.
Iyer, Aishwarya, Sandra O’Keefe, Jordan Patterson, et al.. (2020). Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma. Blood Advances. 4(11). 2489–2500. 43 indexed citations
14.
Su, Ma, Weiwei Wang, Feng Liu, & Huanqiu Li. (2020). Recent Progress on the Discovery of NLRP3 Inhibitors and their Therapeutic Potential. Current Medicinal Chemistry. 28(3). 569–582. 16 indexed citations
15.
Li, Kay Ka‐Wai, Weiwei Wang, Aden Ka‐Yin Chan, et al.. (2020). Clinical and mutational profiles of adult medulloblastoma groups. Acta Neuropathologica Communications. 8(1). 191–191. 39 indexed citations
16.
Iyer, Aishwarya, Sandra O’Keefe, Jordan Patterson, et al.. (2019). Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing. Blood Advances. 3(7). 1175–1184. 34 indexed citations
17.
Wang, Weiwei & Xun Wu. (2018). Cingulate gyrus: anatomy, physiology and epileptic seizure. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Gao, Guofeng, Binzhi Zhang, Ganesan Ramesh, et al.. (2013). TNF-α mediates increased susceptibility to ischemic AKI in diabetes. American Journal of Physiology-Renal Physiology. 304(5). F515–F521. 68 indexed citations
19.
Huang, Damao, Weiwei Wang, Feng Zhu, et al.. (2011). Berberine inhibits the invasion and metastasis of nasopharyngeal carcinoma cells through Ezrin phosphorylation.. PubMed. 36(7). 616–23. 5 indexed citations
20.
Wang, Weiwei, et al.. (2010). The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro. SHILAP Revista de lepidopterología. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026